Coronary Artery Restenosis Terminated Phase 2 Trials for Serine (DB00133)

Also known as: Restenosis, Coronary / Coronary Restenosis

IndicationStatusPhase
DBCOND0032386 (Coronary Artery Restenosis)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00243308Serp-1 for the Treatment of Acute Coronary SyndromeDiagnostic